Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. 2004

W-S Ahn, and D-J Kim, and G-T Chae, and J-M Lee, and S-M Bae, and J-I Sin, and Y-W Kim, and S-E Namkoong, and I P Lee
Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul, South Korea. ahnws@catholic.ac.kr

A mushroom extract, Agaricus blazei Murill Kyowa (ABMK), has been reported to possess antimutagenic and antitumor effects. Here, we investigate the beneficial effects of ABMK consumption on immunological status and qualities of life in cancer patients undergoing chemotherapy. One hundred cervical, ovarian, and endometrial cancer patients were treated either with carboplatin (300 mg / m(2)) plus VP16 (etoposide, 100 mg / m(2)) or with carboplatin (300 mg / m(2)) plus taxol (175 mg / m(2)) every 3 weeks for at least three cycles with or without oral consumption of ABMK. We observed that natural killer cell activity was significantly higher in ABMK-treated group (ANOVA, n = 39, P < 0.002) as compared with nontreated placebo group (n = 61). However, no significant difference in lymphokine-activated killer and monocyte activities was observed in a manner similar to the count of specific immune cell populations between ABMK-treated and nontreated groups. However, chemotherapy-associated side effects such as appetite, alopecia, emotional stability, and general weakness were all improved by ABMK treatment. Taken together, this suggests that ABMK treatment might be beneficial for gynecological cancer patients undergoing chemotherapy.

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D005047 Etoposide A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. Demethyl Epipodophyllotoxin Ethylidine Glucoside,Celltop,Eposide,Eposin,Eto-GRY,Etomedac,Etopos,Etoposide Pierre Fabre,Etoposide Teva,Etoposide, (5S)-Isomer,Etoposide, (5a alpha)-Isomer,Etoposide, (5a alpha,9 alpha)-Isomer,Etoposide, alpha-D-Glucopyranosyl Isomer,Etoposido Ferrer Farma,Exitop,Lastet,NSC-141540,Onkoposid,Riboposid,Toposar,VP 16-213,VP-16,Vepesid,Vépéside-Sandoz,Eto GRY,Etoposide, alpha D Glucopyranosyl Isomer,NSC 141540,NSC141540,Teva, Etoposide,VP 16,VP 16 213,VP 16213,VP16,Vépéside Sandoz,alpha-D-Glucopyranosyl Isomer Etoposide
D005260 Female Females
D005833 Genital Neoplasms, Female Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE). Gynecologic Neoplasms,Female Genital Neoplasms,Neoplasms, Female Genital,Neoplasms, Gynecologic,Female Genital Neoplasm,Genital Neoplasm, Female,Gynecologic Neoplasm,Neoplasm, Female Genital,Neoplasm, Gynecologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

W-S Ahn, and D-J Kim, and G-T Chae, and J-M Lee, and S-M Bae, and J-I Sin, and Y-W Kim, and S-E Namkoong, and I P Lee
October 2013, Complementary therapies in medicine,
W-S Ahn, and D-J Kim, and G-T Chae, and J-M Lee, and S-M Bae, and J-I Sin, and Y-W Kim, and S-E Namkoong, and I P Lee
June 2007, Immunology,
W-S Ahn, and D-J Kim, and G-T Chae, and J-M Lee, and S-M Bae, and J-I Sin, and Y-W Kim, and S-E Namkoong, and I P Lee
April 2008, Journal of alternative and complementary medicine (New York, N.Y.),
W-S Ahn, and D-J Kim, and G-T Chae, and J-M Lee, and S-M Bae, and J-I Sin, and Y-W Kim, and S-E Namkoong, and I P Lee
May 2009, Clinical and molecular allergy : CMA,
W-S Ahn, and D-J Kim, and G-T Chae, and J-M Lee, and S-M Bae, and J-I Sin, and Y-W Kim, and S-E Namkoong, and I P Lee
October 2008, Scandinavian journal of immunology,
W-S Ahn, and D-J Kim, and G-T Chae, and J-M Lee, and S-M Bae, and J-I Sin, and Y-W Kim, and S-E Namkoong, and I P Lee
January 2017, BioMed research international,
W-S Ahn, and D-J Kim, and G-T Chae, and J-M Lee, and S-M Bae, and J-I Sin, and Y-W Kim, and S-E Namkoong, and I P Lee
April 2006, Shock (Augusta, Ga.),
W-S Ahn, and D-J Kim, and G-T Chae, and J-M Lee, and S-M Bae, and J-I Sin, and Y-W Kim, and S-E Namkoong, and I P Lee
October 2005, Scandinavian journal of immunology,
W-S Ahn, and D-J Kim, and G-T Chae, and J-M Lee, and S-M Bae, and J-I Sin, and Y-W Kim, and S-E Namkoong, and I P Lee
January 2013, In vivo (Athens, Greece),
W-S Ahn, and D-J Kim, and G-T Chae, and J-M Lee, and S-M Bae, and J-I Sin, and Y-W Kim, and S-E Namkoong, and I P Lee
January 2022, Current research in food science,
Copied contents to your clipboard!